Investing Profile

Elena Viboch

InvestorVC
Managing Director at General Catalyst
generalcatalyst.comSan Francisco Bay Area
Photo of Elena Viboch, Managing Director at General Catalyst

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Connected to 2 investors on Signal.

Sign in with Google →
NewCo Network
1601 CONNECTIONS
NewCo Network
1601 CONNECTIONS
Top-Patents Network
1032 CONNECTIONS
Top-Patents Network
1032 CONNECTIONS
BlueStone Capital Partners, L.P. Network
515 CONNECTIONS
cb
General Catalyst Managing Director
$500K - $2.0M
$500K
29
$1.1B
CompanyStageDateRound SizeTotal Raised
Chai Discovery
Series CJul 2026$400M
Series BDec 2025$130M
$630M
Co-investors: Nina Achadjian (Index Ventures), Hemant Taneja (General Catalyst), Patrick Grady (Sequoia Capital), Fred Ehrsam (Paradigm), Greg Yap (Menlo Ventures), Lachy Groom (Physical Intelligence), Annie Lamont (Oak HC/FT), Zavain Dar (Dimension Capital), Nitesh Banta (Getaround), Ilya Fushman (Kleiner Perkins)
Parabilis Medicines
Series FJan 2026$310M
Series EMar 2024$150M
$800M
Co-investors: Krishna Yeshwant (GV (Google Ventures)), Corey Goodman (venBio Partners), Thilo Schroeder (Nextech Invest), Jake Simson (RA Capital Management)
Paradigm
Series BDec 2025$78M
Series AJan 2023$200M
$320M
Co-investors: Hemant Taneja (General Catalyst), Niko Bonatsos (General Catalyst), David Schenkein (GV (Google Ventures)), Max Rimpel (Index Ventures), Bilal Zuberi (Lux Capital), Stephen Knight (F-Prime Capital Partners), Brett Cook (F-Prime Capital Partners), Ramnik Arora (Original Capital), Arash Ferdowsi (Dropbox), Eoghan McCabe (Spark-Local, Inc), Jay Markowitz (ARCH Venture Partners), Robert Nelsen (ARCH Venture Partners), Alaa Halawa (Mubadala), Justin Kao (DFJ Growth), Jared Friedman (Y Combinator), Scott Belsky (A24), Karim Atiyeh, Balaji Srinivasan
Tahoe Therapeutics
Series AAug 2025$30M
SeedDec 2022$12M
$42M
Co-investors: Gaurav Garg (Wing Venture Capital), Deep Nishar (General Catalyst), Krish Ramadurai (Harmonix Fund), Sunil Dhaliwal (Amplify Partners), Ayman AlAbdallah
Maxion Therapeutics
Series AMar 2025$75M
$91M
Co-investors: Lucy Edwardes-Jones (BGF Ventures)
Eikon Therapeutics
Series DFeb 2025$350M
Series BJan 2022$520M
$1B
Co-investors: Adam Goulburn (6 Dimensions Capital), Larry Lasky (The Column Group), Leon Chen (The Column Group), Josh Wolfe (Lux Research), Eric Schmidt (Innovation Endeavors), Dror Berman (Innovation Endeavors)
Manas AI
SeedJan 2025$25M
$25M
Co-investors: Hemant Taneja (General Catalyst), Reid Hoffman (Greylock)
Medeloop
Series ANov 2024$16M
SeedSep 2023$8M
$24M
Co-investors: Sara Thomas Deshpande (Maven Ventures), Magaly Charbonneau (iNovia Capital)
Managing Director General Catalyst2024 - Present
Senior Manager, Corporate Development & Strategy Still Water DesignPresent
Director of Business Development & Operations Still Water DesignPresent
Senior Manager, Corporate Development & Strategy BlueStone Capital Partners, L.P.Present
Director of Business Development & Operations BlueStone Capital Partners, L.P.Present
Director of Business Development & Operations FLX Bio, Inc.Present
Consultant PutnamPresent
Senior Manager, Corporate Development & Strategy Top-PatentsPresent
Director of Business Development & Operations Top-PatentsPresent
Partner General Catalyst PartnersPresent
Managing Director General Catalyst PartnersPresent
Senior Manager, Corporate Development & Strategy NewCoPresent
Director of Business Development & Operations NewCoPresent
Partner General Catalyst2022 - 2024
Investment Director SoftBank Investment Advisers2019 - 2022
Director of Corporate Development NanoString Technologies, Inc.2017 - 2019
Director of Business Development & Operations Carmot Therapeutics2016 - 2017
Senior Manager, Corporate Development & Strategy FLX Bio, Inc.2015 - 2016
Corporate Development Jazz Pharmaceuticals2014 - 2014
Investor Kearny Venture Partners2011 - 2014
Consultant Putnam Associates2009 - 2011
The Johns Hopkins University Master of Science - MS Biotechnology
Sign in with Google →
Sign in with Google →